Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05654246 · ClinicalTrials.gov registry record
Susan G. Komen's ShareForCures
A clinical trial of Breast Cancer, sponsored by Susan G. Komen Breast Cancer Foundation.
- Recruiting
- Registry status
- 200,000
- Enrollment target
- 1
- Study location
NCT05654246: Recruiting study of Breast Cancer, sponsored by Susan G. Komen Breast Cancer Foundation.
NCT05654246 is a study of Breast Cancer that is actively recruiting participants, run by Susan G. Komen Breast Cancer Foundation. The registered enrollment target is 200,000 participants, above the 2,640-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (7476% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05654246, a study of Breast Cancer, is actively recruiting participants, sponsored by Susan G. Komen Breast Cancer Foundation.
- RECRUITING
- Registry status
- 200,000 participants
- Enrollment target
- 1
- Study location
Study Summary
ShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer patient population -including minoritized and historically marginalized people, persons, or communities-to ensure the data researchers use to study breast cancer is as diverse as the people touched by this disease. In doing so, researchers will have a better understanding of breast cancer, and everyone can potentially benefit from scientific advances and improvements in care.
Primary Outcome
Enroll and engage up to 200,000 people, who have been diagnosed with breast cancer, reflecting the diversity of breast cancer survivors within the United States, to participate in the registry as our partners in research.
Conditions Studied
Study Locations (1)
Texas
- Susan G. Komen - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2022-11-17 |
| Est. Completion | 2032-11 |
What NCT05654246 shows while recruiting
NCT05654246 is an observational study that tracks outcomes without assigning an intervention. Its 200,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,640-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (7476% higher).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05654246 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05654246 about?
NCT05654246 is a clinical study titled "Susan G. Komen's ShareForCures". ShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer patient population -including minoritized and historically marginalized people, persons, or communities-to ensure the data res...
What is the current status of trial NCT05654246?
This trial is currently recruiting. The enrollment target is 200,000 participants. The study started on 2022-11-17. Estimated completion is 2032-11.
What conditions does trial NCT05654246 study?
This clinical trial studies the following conditions: Breast Cancer.
Who is sponsoring clinical trial NCT05654246?
This trial is sponsored by Susan G. Komen Breast Cancer Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05654246 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05654246's enrollment target sits among peer trials
200,000 3rd of 1224 higher than 1,222 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI